SeaCrest Wealth Management’s Medifast MED Stock Holding History

SeaCrest Wealth Management’s Portfolio MED Stock Details MED Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-150	Closed	-$19K	–	1299
2019 Q1	$19K	Sell	150 -4	-3%	-$507	﹤0.01%	1311
2018 Q4	$19K	Sell	154 -150	-49%	-$25.7K	﹤0.01%	1255
2018 Q3	$67K	Sell	304 -1,200	-80%	-$243K	0.01%	896
2018 Q2	$241K	Buy	1,504 +1,500	+37,500%	+$192K	0.04%	429
2018 Q1	$0	Hold	4	–	–	﹤0.01%	2248
2017 Q4	$0	Buy	+4	New	+$265	﹤0.01%	2231

Other funds holding MED

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

HCM

Hoplite Capital Management New York $15.1M AUM 27.41% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

AAMU

Amundi Asset Management US Boston, Massachusetts $131B AUM 73.57% 1-Year Est. Return

PAMU

Pictet Asset Management (UK) London, United Kingdom $91.8B AUM 47.77% 1-Year Est. Return

HRCM

Hood River Capital Management Palm Beach Gardens, Florida $9.98B AUM 145.42% 1-Year Est. Return

SeaCrest Wealth Management's MED Position: Q2 2019 in Review

SeaCrest Wealth Management sold out of Medifast (MED) in Q2 2019, closing a stake of 150 shares — an estimated $19K sold.

SeaCrest Wealth Management first reported a position in MED in Q4 2017 and held it in 6 quarters. The position peaked at $241K in Q2 2018. 251 funds tracked by Wall St. Rank hold MED as of Q2 2019.

SeaCrest Wealth Management reported no remaining Medifast position as of Q2 2019 after selling out during the quarter.
SeaCrest Wealth Management sold 150 Medifast shares in Q2 2019, an estimated $19K.
SeaCrest Wealth Management first reported a position in Medifast in Q4 2017 and held it in 6 quarters.
SeaCrest Wealth Management's Medifast position peaked at $241K in Q2 2018.
251 funds tracked by Wall St. Rank held Medifast as of Q2 2019.

Based on SeaCrest Wealth Management's 13F filing for Q2 2019, filed 19 Jul 2019.